Flow Diversion Aneurysm Treatment Market | Leading Segments, Trends, Drivers and Challenges
Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson and Johnson Inc., Medtronic Plc, are among the leading market vendors
Global flow diversion aneurysm treatment market is likely to post an incremental growth of $ 1.75 billion, accelerating at a CAGR of over 8.26% during the forecast period. This research provides a detailed analysis of the market segments and geographic landscape. It also offers insights into the various growth factors aswell as challenges that are likely to have a negative impact on market growth. This thorough research will equip clients with the insights necessary to plan and strategize a post-pandemic recovery plan.
Request for Our Free Sample Report for detailed Insights
Flow Diversion Aneurysm Treatment Market: Market Segments and Growth Forecasts
This research report will provide insights into the current market share of each segment along with growth projections for the next five years.
- Market is segmented by Product (intrasaccular flow disruption devices and FDS) and Geography (North America, Europe, Asia, and ROW).
- Growth by the FDS product segment will be significant during the forecast period due to the increasing adoption of technologically advanced FDS, increasing awareness of the clinical advantages of advanced FDS over conventional approaches such as surgical clipping and endovascular coiling, expanding indications of FDS, and new product launches.
- 40% of the market growth will originate from North America during the forecast period with the US and Canada being the key markets for flow diversion aneurysm treatment in the region. High awareness about the impact and treatment procedures for aneurysms, the increasing number of flow diversion procedures being performed, good healthcare infrastructure, and increased healthcare expenditure are factors that contribute to the flow diversion aneurysm treatment market growth in this region. However, the market growth rate in this region will be slower than the growth of the market in Asia which is rapidly building up its healthcare infrastructure.
- This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Flow Diversion Aneurysm Treatment Market size.
Flow Diversion Aneurysm Treatment Market: Trends, Drivers, Challenges
The report also offers a detailed impact analysis of various trends, drivers, and challenges that are likely to influence the market growth during the forecast period. These insights will equip clients to design a growth strategy for their business and area of operations.
- Increasing prevalence of intracranial aneurysms (IAs) and associated risk factors will be a significant factor in driving the growth of the Flow Diversion Aneurysm Treatment Market. The risk of IAs significantly increases with age and looking at the increasing life expectancy we are likely to have a huge aging population during the forecast period. Other risk factors associated with IAs, such as hypertension, smoking, and excessive alcohol consumption, are also on the rise. It is estimated that about 1.10 billion -1.15 billion people worldwide are living with hypertension. An increase in the number of people vulnerable to aneurysms is anticipated to drive the demand for flow diversion aneurysm treatment products during the forecast period.
- Increasing preference for flow diversion aneurysm treatment will be instrumental in driving the market growth during the forecast period. Several major manufacturers and distributors of neuro endovascular treatment devices are significantly investing in R&D to enter the global flow diverters market, owing to the increasing acceptance of flow diversion devices in clinical practice.
- Lack of awareness and access to flow diversion procedures in emerging countries is a hurdle that needs to be crossed on the path to success. There is also a global shortage of neurologists and neurosurgeons capable of performing flow diversion procedures. This shortage is particularly acute in low and middle-income regions such as Southeast Asia and Africa. However, with growing economic scenario and government focus on building healthcare infrastructure this issue is likely to get resolved over the coming years.
Flow Diversion Aneurysm Treatment Market: Vendor Analysis
- The market is concentrated.
- Acandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson and Johnson Inc., Medtronic Plc, MicroPort Scientific Corp., phenox GmbH, Stryker Corp., and Terumo Corp. are some of the major market participants.
- The unprecedented outbreak of COVID-19 in 2020 has had a significant impact on market segments had a ripple effect on various stakeholders. Our vendor analysis and insights will provide you with all the information required to make the most of the opportunities and plan business recovery and growth post the pandemic.
Key Areas Covered in our Report:
- Flow Diversion Aneurysm Treatment Market Split by Product
- Intrasaccular flow disruption devices
- FDS
- Flow Diversion Aneurysm Treatment Market Split by Geography
- North America
- Europe
- Asia
- ROW
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- APAC - Market size and forecast 2020-2025
- MEA - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- North America - Market size and forecast 2020-2025
- South America - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Competitive scenario
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Acandis GmbH
- Boston Scientific Corp.
- Cardinal Health Inc.
- Cook Group Inc.
- Johnson and Johnson Inc.
- Medtronic Plc
- MicroPort Scientific Corp.
- phenox GmbH
- Stryker Corp.
- Terumo Corp.
For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.
The report provides insights into the following FAQs:
- What is the market CAGR?
The market will accelerate at a CAGR of over 8.26%.
- What is the incremental growth of the market?
The market is expected to grow by $ 1.75 bn through 2021-2025.
- What is a key factor driving this market?
Increasing prevalence of IAs and associated risk factors will drive market growth over the forecast period.
- What are the key regions covered in this market research report?
North America, Europe, Asia, and ROW are the key regions featured in this research report.
- Which is the leading geographic region for this market:
40% growth will originate from North America
- Who are the leading market vendors?
The leading vendors in this market are Acandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson and Johnson Inc., Medtronic Plc, MicroPort Scientific Corp., phenox GmbH, Stryker Corp., and Terumo Corp.
- What are the market segments covered in this report?
The market is segmented by Product (intrasaccular flow disruption devices and FDS) and Geography (North America, Europe, Asia, and ROW)
Flow Diversion Aneurysm Treatment: Top Drivers that will Enable COVID-19 Recovery
Market Insights to Drive Recovery from COVID-19
Technavio’s Flow Diversion Aneurysm Treatment Market is set to grow by $ 1.75 bn, and the market will progressing at a CAGR of over 8.26% till 2025. This research report identifies and analyses the growth drivers that will boost market growth. It also provides a thorough understanding of all the segments, trends and challenges that are likely to have an impact on the future prospects fo the market in focus.
Request for our free sample report to get a glimpse into our exhaustive research and analysis: Download FREE Sample Report
Flow Diversion Aneurysm Treatment Market: Key Market Drivers
^A detailed study of market drivers enables market players to leverage these factors to drive growth. Technavio’s research reports provide a comprehensive analysis of all the other factors that will drive market growth during the forecast period. In addition to market drivers, our research report also studies the latest trends and challenges that are likely to influence growth in the current market scenario. One of the key drivers that will boost this market is Increasing prevalence of IAs and associated risk factors. For more insights on the impact of this and all the other drivers, Request our Free Sample Report
Flow Diversion Aneurysm Treatment Market: Growth Segments
This research report provides insights into the current market share of each segment along with growth projections for the next five years. In addition, the report also offers a detailed impact analysis of various trends, drivers, and challenges on each market segment along with insights into the way forward. These insights will equip clients with information that will help them design a growth strategy for their business and area of operation. Flow Diversion Aneurysm Treatment Market is segmented by Product (FDS and Intrasaccular flow disruption devices) and Geography (North America, Europe, Asia, and ROW).
Flow Diversion Aneurysm Treatment Market: Vendor Analysis
The market is concentrated due to the presence of several players. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Acandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson and Johnson Inc., Medtronic Plc, MicroPort Scientific Corp., phenox GmbH, Stryker Corp., and Terumo Corp. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.
Technavio also offers custom research reports with detailed insights assessing the market from a global as well as regional perspective. This customized report will help clients keep up with new product launches in direct & indirect or related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations. For more insights on this market: Download a Free Sample Report
